Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Capital Inc. Bioengine currently holds 1,239,088 shares of WINDTREE THERAPEUTICS INC /DE/ (WINT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Capital Inc. Bioengine has been a net seller of WINT stock. They have purchased $400.0K and sold $2.0M worth of shares.
Capital Inc. Bioengine's most recent insider trade was on Dec 30, 2021, when they sold 1,239,088 shares at $1.60 per share.
Capital Inc. Bioengine serves as Executive at WINDTREE THERAPEUTICS INC /DE/ (WINT). They have executed 3 insider transactions totaling $2.4M over their tenure at the company.
Capital Inc. Bioengine holds the position of Executive at WINDTREE THERAPEUTICS INC /DE/, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Capital Inc. Bioengine has shown a selling trading pattern, with $400.0K in total purchases and $2.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Capital Inc. Bioengine was on Dec 30, 2021, when they sold $2.0M worth of WINT shares. This transaction involved 1,239,088 shares at $1.60 per share.
Capital Inc. Bioengine currently owns 1,239,088 shares of WINDTREE THERAPEUTICS INC /DE/ (WINT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Capital Inc. Bioengine's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Capital Inc. Bioengine has 3 Form 4 filings on record as an insider at WINDTREE THERAPEUTICS INC /DE/.
Set alerts for Capital Inc. Bioengine and 40,000+ other insiders.